and, as additional funding becomes available, to c
Post# of 72436
![](/assets/46931549/no_avatar_available_thumb.jpg)
....
Kevetrin for Ovarian Cancer
· Next steps, building on our successful completed Phase 2a study in Ovarian Cancer, are planned to focus on completion of toxicology studies necessary for the oral formulation of Kevetrin and to prepare an appropriate oral dosage form to further evaluate the drug candidate’s clinical benefits and safety.
https://www.ipharminc.com/press-release/2018/...ormulation
That's where we were in September.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)